blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2051981

EP2051981 - 1H-FURO[3,2-C] PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.07.2011
Database last updated on 24.08.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
NERVIANO MEDICAL SCIENCES S.R.L.
Viale Pasteur, 10
20014 Nerviano (MI) / IT
[2010/34]
Former [2009/18]For all designated states
NERVIANO MEDICAL SCIENCES S.r.l.
Viale Pasteur, 10
20014 Nerviano (MI) / IT
Inventor(s)01 / FANCELLI, Daniele
Via Montecuccoli 8
20147 Milan / IT
02 / PULICI, Maurizio
Via T.Speri 31
20040 Caponago (MI) / IT
03 / MOLL, Jurgen
Località San Bartolomeo
22070 Appiano Gentile (CO) / IT
04 / BANDIERA, Tiziano
C.So Vittorio Emanuele 44
27025 Gambolò (PV) / IT
 [2009/18]
Application number, filing date07729539.225.05.2007
[2009/18]
WO2007EP55113
Priority number, dateEP2006011474731.05.2006         Original published format: EP 06114747
[2009/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007138017
Date:06.12.2007
Language:EN
[2007/49]
Type: A1 Application with search report 
No.:EP2051981
Date:29.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 06.12.2007 takes the place of the publication of the European patent application.
[2009/18]
Type: B1 Patent specification 
No.:EP2051981
Date:25.08.2010
Language:EN
[2010/34]
Search report(s)International search report - published on:EP06.12.2007
ClassificationIPC:C07D491/04, A61K31/4162, A61P35/00
[2009/18]
CPC:
C07D491/048 (EP,US); A61P11/00 (EP); A61P13/08 (EP);
A61P13/12 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P27/02 (EP); A61P3/04 (EP); A61P31/12 (EP);
A61P35/00 (EP); A61P35/04 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/18]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:1H-FURO[3,2-C] PYRAZOLVERBINDUNGEN, DIE SICH ALS KINASEINHIBITOREN EIGNEN[2009/18]
English:1H-FURO[3,2-C] PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS[2009/18]
French:COMPOSÉS DE 1H-FURO[3,2-C] PYRAZOLE UTILES EN TANT QU'INHIBITEURS DE KINASES[2009/18]
Entry into regional phase19.12.2008National basic fee paid 
19.12.2008Designation fee(s) paid 
19.12.2008Examination fee paid 
Examination procedure19.12.2008Amendment by applicant (claims and/or description)
19.12.2008Examination requested  [2009/18]
01.10.2009Communication of intention to grant the patent
27.01.2010Fee for grant paid
27.01.2010Fee for publishing/printing paid
Opposition(s)26.05.2011No opposition filed within time limit [2011/31]
Fees paidRenewal fee
27.05.2009Renewal fee patent year 03
25.05.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY25.08.2010
CZ25.08.2010
DK25.08.2010
EE25.08.2010
FI25.08.2010
HU25.08.2010
LT25.08.2010
LV25.08.2010
MT25.08.2010
PL25.08.2010
RO25.08.2010
SI25.08.2010
SK25.08.2010
TR25.08.2010
BG25.11.2010
GR26.11.2010
IS25.12.2010
PT27.12.2010
LU25.05.2011
[2013/45]
Former [2013/44]CY25.08.2010
CZ25.08.2010
DK25.08.2010
EE25.08.2010
FI25.08.2010
LT25.08.2010
LV25.08.2010
MT25.08.2010
PL25.08.2010
RO25.08.2010
SI25.08.2010
SK25.08.2010
TR25.08.2010
BG25.11.2010
GR26.11.2010
IS25.12.2010
PT27.12.2010
LU25.05.2011
Former [2013/25]CY25.08.2010
CZ25.08.2010
DK25.08.2010
EE25.08.2010
FI25.08.2010
LT25.08.2010
LV25.08.2010
MT25.08.2010
PL25.08.2010
RO25.08.2010
SI25.08.2010
SK25.08.2010
BG25.11.2010
GR26.11.2010
IS25.12.2010
PT27.12.2010
LU25.05.2011
Former [2012/05]CY25.08.2010
CZ25.08.2010
DK25.08.2010
EE25.08.2010
FI25.08.2010
LT25.08.2010
LV25.08.2010
MT25.08.2010
PL25.08.2010
RO25.08.2010
SI25.08.2010
SK25.08.2010
BG25.11.2010
GR26.11.2010
IS25.12.2010
PT27.12.2010
Former [2011/26]CY25.08.2010
CZ25.08.2010
DK25.08.2010
EE25.08.2010
FI25.08.2010
LT25.08.2010
LV25.08.2010
PL25.08.2010
RO25.08.2010
SI25.08.2010
SK25.08.2010
BG25.11.2010
GR26.11.2010
IS25.12.2010
PT27.12.2010
Cited inInternational search[AD]WO2004007504  (PHARMACIA ITALIA SPA [IT], et al) [AD] 1-23* example - *;
 [A]WO2005074922  (PHARMACIA ITALIA SPA [IT], et al) [A] 1-23 * example - *;
 [PX]WO2007009898  (NERVIANO MEDICAL SCIENCES SRL [IT], et al) [PX] 1-23 * example - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.